Showing results (731-740 of 10,307) with videos related to
Sort By:
Pageof 1,031
Vaccines|November 27, 2021
Enhancement of the Local CD8+ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX AntigensKirill Vasilyev, Anna-Polina Shurygina, Natalia Zabolotnykh, et al.Vaccines|November 27, 2021
Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart ImmunotherapyNoha M Hammad, Ayman Marei, Gamal El-Didamony, et al.Vaccines|November 27, 2021
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIVRos Chapman, Michiel van Diepen, Nicola Douglass, et al.Vaccines|November 27, 2021
Body Appreciation as a Factor Associated with College Students' Willingness to Receive Future COVID-19 VaccinesZi-Han Liu, Wei Bai, Hong Cai, et al.Vaccines|November 27, 2021
Willingness to Receive the Booster COVID-19 Vaccine Dose in PolandPiotr Rzymski, Barbara Poniedziałek, Andrzej FalVaccines|November 27, 2021
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion DomainXinyue Chang, Andris Zeltins, Mona O Mohsen, et al.Vaccines|November 27, 2021
Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign-A Case of Measles-Rubella and Polio VaccinesDan Kajungu, Victoria Nambasa, Michael Muhoozi, et al.Vaccines|November 27, 2021
Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine?Norio Sugawara, Norio Yasui-Furukori, Atsuhito Fukushima, et al.Vaccines|November 27, 2021
Riboflavin as a Mucosal Adjuvant for Nasal Influenza VaccineYinyan Yin, Jinyuan Wang, Xing Xu, et al.Vaccines|November 27, 2021
COVID-19 Vaccine Boosters: The Good, the Bad, and the UglyPiotr Rzymski, Carlos A Camargo, Andrzej Fal, et al.Pageof 1,031